Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2022 07:00 ET | Source: Societal CDMO, Inc.

Societal CDMO Appoints Elena Cant to Board of Directors

SAN DIEGO and GAINESVILLE, Ga., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
May 17, 2022 08:00 ET | Source: BrightInsight

BrightInsight Adds Biopharma Technology and Digital Health Expert, Karl Hick, to Advisory Council

SAN JOSE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the...
April 28, 2022 06:30 ET | Source: Centogene NV

CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally

Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic...
March 12, 2022 13:18 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING LAW FIRM, Encourages Shattuck Labs, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – STTK

NEW YORK, March 12, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or...
March 07, 2022 14:01 ET | Source: The Rosen Law Firm PA

STTK SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – STTK

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or...
February 20, 2022 16:30 ET | Source: The Rosen Law Firm PA

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – STTK

NEW YORK, Feb. 20, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or...
February 05, 2022 11:52 ET | Source: The Rosen Law Firm PA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 1 Deadline in Securities Class Action Commenced by the Firm – STTK

NEW YORK, Feb. 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or...
February 01, 2022 09:45 ET | Source: The Rosen Law Firm PA

STTK INVESTOR NEWS: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – STTK

NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
August 12, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline: Insights into New Pipeline Therapies and Landscape; Future Key Pharma Companies and Novel Therapeutic Assessment

Los Angeles, USA, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Alpha-1 Antitrypsin Deficiency Liver Disease Pipeline: Insights into New Pipeline Therapies and Landscape; Future Key Pharma Companies and Novel...
April 14, 2021 06:30 ET | Source: CENTOGENE GmbH

CENTOGENE Extends Partnership With Takeda

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right